Sunshine Biopharma shareholders elect all five directors and approve equity plan increase at annual meeting

Sunshine Biopharma Inc.

All five director nominees elected: Dr. Slilaty, Sebaaly, Kiderchah, Natan, Keller received over 130M votes for.
Ratification of M&K CPAS as independent auditor for 2025 approved with 132M for, 178K against.
Amendment to 2023 Equity Incentive Plan to increase authorized shares to 683,000 approved with 130M for, 294K against.
Broker non-votes: 1.77M on director elections and equity plan; 0 on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.